APA (7th ed.) Citation

Platzbecker, U., & Nolte, F. (2014). Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients. Leukemia, 28(3), . https://doi.org/10.1038/leu.2013.325

Chicago Style (17th ed.) Citation

Platzbecker, Uwe, and Florian Nolte. "Phase 2 Study of Oral Panobinostat (LBH589) with or Without Erythropoietin in Heavily Transfusion-dependent IPSS Low or Int-1 MDS Patients." Leukemia 28, no. 3 (2014). https://doi.org/10.1038/leu.2013.325.

MLA (9th ed.) Citation

Platzbecker, Uwe, and Florian Nolte. "Phase 2 Study of Oral Panobinostat (LBH589) with or Without Erythropoietin in Heavily Transfusion-dependent IPSS Low or Int-1 MDS Patients." Leukemia, vol. 28, no. 3, 2014, https://doi.org/10.1038/leu.2013.325.